Captrust Financial Advisors Bristol Myers Squibb CO Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
A detailed history of Captrust Financial Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Captrust Financial Advisors holds 523,325 shares of BMY stock, worth $24.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
523,325
Previous 543,361
3.69%
Holding current value
$24.4 Million
Previous $33.1 Million
26.9%
% of portfolio
0.06%
Previous 0.09%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,667Shares Held
1.56BCall Options Held
23.1MPut Options Held
24.5M-
Vanguard Group Inc Valley Forge, PA196MShares$9.14 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.51 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.41 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...